INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:INSP - US4577301090 - Common Stock
136.81 USD
-3.22 (-2.3%)
137.5 USD
+0.69 (+0.5%)
Overall INSP gets a fundamental rating of 6 out of 10. We evaluated INSP against 188 industry peers in the Health Care Equipment & Supplies industry. INSP has an excellent financial health rating, but there are some minor concerns on its profitability. INSP is valued quite expensively, but it does show have an excellent growth rating. These ratings would make INSP suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year INSP was profitable.
In the past year INSP had a positive cash flow from operations.
In the past 5 years INSP reported 4 times negative net income.
In multiple years INSP reported negative operating cash flow during the last 5 years.
1.2 Ratios
INSP's Return On Assets of 5.52% is amongst the best of the industry. INSP outperforms 82.45% of its industry peers.
Looking at the Return On Equity, with a value of 6.69%, INSP belongs to the top of the industry, outperforming 80.85% of the companies in the same industry.
With a decent Return On Invested Capital value of 4.82%, INSP is doing good in the industry, outperforming 76.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROIC | 4.82% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
INSP has a Profit Margin of 5.05%. This is in the better half of the industry: INSP outperforms 77.13% of its industry peers.
The Operating Margin of INSP (4.16%) is better than 69.15% of its industry peers.
Looking at the Gross Margin, with a value of 84.92%, INSP belongs to the top of the industry, outperforming 94.15% of the companies in the same industry.
In the last couple of years the Gross Margin of INSP has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
INSP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
INSP has more shares outstanding than it did 1 year ago.
The number of shares outstanding for INSP has been increased compared to 5 years ago.
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 18.74 indicates that INSP is not in any danger for bankruptcy at the moment.
INSP's Altman-Z score of 18.74 is amongst the best of the industry. INSP outperforms 94.68% of its industry peers.
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 18.74 |
ROIC/WACC0.55
WACC8.75%
2.3 Liquidity
A Current Ratio of 5.29 indicates that INSP has no problem at all paying its short term obligations.
With an excellent Current ratio value of 5.29, INSP belongs to the best of the industry, outperforming 80.32% of the companies in the same industry.
A Quick Ratio of 4.01 indicates that INSP has no problem at all paying its short term obligations.
With a decent Quick ratio value of 4.01, INSP is doing good in the industry, outperforming 76.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 |
3. Growth
3.1 Past
INSP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 90.65%, which is quite impressive.
INSP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.81%.
The Revenue has been growing by 57.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
3.2 Future
The Earnings Per Share is expected to grow by 21.35% on average over the next years. This is a very strong growth
INSP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.59% yearly.
EPS Next Y-70.2%
EPS Next 2Y-3.49%
EPS Next 3Y16.27%
EPS Next 5Y21.35%
Revenue Next Year13.03%
Revenue Next 2Y13.73%
Revenue Next 3Y13.96%
Revenue Next 5Y11.59%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 67.06, the valuation of INSP can be described as expensive.
INSP's Price/Earnings ratio is a bit cheaper when compared to the industry. INSP is cheaper than 67.02% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.46, INSP is valued quite expensively.
Based on the Price/Forward Earnings ratio of 84.91, the valuation of INSP can be described as expensive.
65.96% of the companies in the same industry are more expensive than INSP, based on the Price/Forward Earnings ratio.
INSP is valuated expensively when we compare the Price/Forward Earnings ratio to 36.10, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 67.06 | ||
| Fwd PE | 84.91 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, INSP is valued a bit cheaper than 64.36% of the companies in the same industry.
INSP's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. INSP is cheaper than 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 40.23 | ||
| EV/EBITDA | 71.68 |
4.3 Compensation for Growth
A more expensive valuation may be justified as INSP's earnings are expected to grow with 16.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.49%
EPS Next 3Y16.27%
5. Dividend
5.1 Amount
INSP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
136.81
-3.22 (-2.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners109.56%
Inst Owner Change-6.75%
Ins Owners0.82%
Ins Owner Change0.2%
Market Cap3.98B
Revenue(TTM)882.62M
Net Income(TTM)44.56M
Analysts73.85
Price Target113.99 (-16.68%)
Short Float %12.79%
Short Ratio2.91
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)193.12%
Min EPS beat(2)114.53%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)144.95%
Min EPS beat(4)54.07%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)284.67%
EPS beat(12)12
Avg EPS beat(12)208.03%
EPS beat(16)16
Avg EPS beat(16)165.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)1.47%
Revenue beat(16)11
Avg Revenue beat(16)3.25%
PT rev (1m)-18.42%
PT rev (3m)-24.61%
EPS NQ rev (1m)1.62%
EPS NQ rev (3m)0.02%
EPS NY rev (1m)1.28%
EPS NY rev (3m)0.91%
Revenue NQ rev (1m)-0.76%
Revenue NQ rev (3m)-0.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 67.06 | ||
| Fwd PE | 84.91 | ||
| P/S | 4.5 | ||
| P/FCF | 40.23 | ||
| P/OCF | 29.74 | ||
| P/B | 5.97 | ||
| P/tB | 5.97 | ||
| EV/EBITDA | 71.68 |
EPS(TTM)2.04
EY1.49%
EPS(NY)1.61
Fwd EY1.18%
FCF(TTM)3.4
FCFY2.49%
OCF(TTM)4.6
OCFY3.36%
SpS30.37
BVpS22.93
TBVpS22.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number32.44
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROCE | 5.27% | ||
| ROIC | 4.82% | ||
| ROICexc | 8.98% | ||
| ROICexgc | 8.98% | ||
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% | ||
| FCFM | 11.2% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score8
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 276.46% | ||
| Cap/Sales | 3.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 270.95% | ||
| Profit Quality | 221.78% | ||
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 | ||
| Altman-Z | 18.74 |
F-Score8
WACC8.75%
ROIC/WACC0.55
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
EPS Next Y-70.2%
EPS Next 2Y-3.49%
EPS Next 3Y16.27%
EPS Next 5Y21.35%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
Revenue Next Year13.03%
Revenue Next 2Y13.73%
Revenue Next 3Y13.96%
Revenue Next 5Y11.59%
EBIT growth 1Y172.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year586.15%
EBIT Next 3Y128.27%
EBIT Next 5Y73.68%
FCF growth 1Y1118.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y401.46%
OCF growth 3YN/A
OCF growth 5YN/A
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
Can you provide the ChartMill fundamental rating for INSPIRE MEDICAL SYSTEMS INC?
ChartMill assigns a fundamental rating of 6 / 10 to INSP.
What is the valuation status of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
ChartMill assigns a valuation rating of 3 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Overvalued.
Can you provide the profitability details for INSPIRE MEDICAL SYSTEMS INC?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.
Can you provide the financial health for INSP stock?
The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 8 / 10.
What is the expected EPS growth for INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The Earnings per Share (EPS) of INSPIRE MEDICAL SYSTEMS INC (INSP) is expected to decline by -70.2% in the next year.